Evoke Pharma Inc Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Evoke Pharma Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Evoke Pharma Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.31M, a 22.5% increase year-over-year.
- Evoke Pharma Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$6.15M, a 19.2% increase year-over-year.
- Evoke Pharma Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$7.79M, a 5.25% increase from 2022.
- Evoke Pharma Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$8.22M, a 3.68% increase from 2021.
- Evoke Pharma Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$8.54M, a 35.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)